Functional diversification is expected to drive the growth of hardware computing beyond the end of Moore's law. Medical application is expected to be a system driver of such diversification. Microfluidic technologies enable miniaturization of laboratory-based biochemical protocols. A microfluidic biochip or lab-on-a-chip (LoC) performs biochemical reactions by consuming nano-/pico-liter volume of reagents. These platforms use less volume of samples and reagents and provide quicker results than the traditional lab. Also, these platforms enable automation that reduces the reliance on high-skilled personnel. Digital microfluidic biochip (DMFB) and continuous flow-based microfluidic biochip (CFMB) are examples of such biochip platforms. CFMBs manipulate fluid flow through a network of micro-channel by actuating pressure-driven micro-valves. DMFB offers a programmable fluidic platform in which discrete fluid droplets can be manipulated through electrical actuations.
ASJC Scopus subject areas
- Computer Science(all)